Abstract
Lung injury limits the success of allogeneic stem cell transplantation (SCT). The overall incidence varies from 30 to 50% and non-infectious causes occur in one-third to one-half of these. We reviewed pulmonary complications in 369 consecutive patients who received a partially T-cell-depleted myeloablative allogeneic hematopoietic SCT at our institution between 1993 and 2003. All patients were treated uniformly with cyclophosphamide followed by total body irradiation. Control subjects were matched on sex, underlying diagnosis, age, type of transplantation and cytomegalovirus (CMV)-serostatus. Sixty-one patients (16.5%) developed pulmonary complications. Twenty-one patients (5.7%) developed infectious pneumonia. Forty patients developed non-infectious complications which were further subclassified as bronchiolitis obliterans (3.5%), bronchiolitis obliterans-organizing pneumonia (0.5%), diffuse alveolar hemorrhage (0.8%), idiopathic pneumonia syndrome (5.5%) or mixed etiology (0.5%). Acute graft-versus-host disease (GVHD) ⩾grade II was significantly more common in pulmonary patients than in the controls (36/61 versus 22/61 patients, P=0.02). There was no significant difference in the incidence of chronic GVHD (P=0.09). CMV reactivation was significantly more frequent in patients with lung injury (P=0.02). Median survival was 41 weeks for the pulmonary patients and 350 weeks for the controls (P=0.001). Altogether, the incidence of pulmonary complications is low after T-cell-depleted SCT and is associated with acute GVHD and CMV reactivation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Breuer R, Lossos IS, Berkman N, Or R . Pulmonary complications of bone marrow transplantation. Respir Med 1993; 87: 571–579.
Cordonnier C, Bernaudin JF, Bierling P, Huet Y, Vernant JP . Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer 1986; 58: 1047–1054.
Krowka MJ, Rosenow III EC, Hoagland HC . Pulmonary complications of bone marrow transplantation. Chest 1985; 87: 237–246.
Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG . Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166: 641–645.
Chen CS, Boeckh M, Seidel K, Clark JG, Kansu E, Madtes DK et al. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 515–522.
Freudenberger TD, Madtes DK, Curtis JR, Cummings P, Storer PE, Hackman RC . Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003; 102: 3822–3828.
Fukuda T, Hackman RC, Guthrie KA, Sandmeier BM, Boeckh M, Maris MB et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003; 102: 2777–2785.
Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ . Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223–229.
Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW . Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63: 1079–1086.
Nusair S, Breuer R, Shapira MY, Berkman N, Or R . Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation. Eur Respir J 2004; 23: 440–445.
Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998; 100: 680–687.
Sakaida E, Nakaseko C, Harima A, Yokota A, Cho R, Saito Y et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003; 102: 4236–4242.
Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 223–230.
Wong R, Rondon G, Saliba RM, Shannon VR, Giralt SA, Champlin RE et al. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer. Bone Marrow Transplant 2003; 31: 1157–1163.
Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH . NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1601–1606.
Crawford SW, Hackman RC . Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1393–1400.
Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HE, Kolb HJ et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 1986; 104: 168–175.
Cooke KR, Yanik G . Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant 2004; 34: 753–765.
Crawford SW, Clark JG . Bronchiolitis associated with bone marrow transplantation. Clin Chest Med 1993; 14: 741–749.
Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW . Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988; 72: 621–627.
Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.
Weisdorf DJ . Diffuse alveolar hemorrhage: an evolving problem? Leukemia 2003; 17: 1049–1050.
Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK . Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 1994; 83: 3090–3096.
Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895–902.
van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI, van Kraaij MG et al. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 2004; 189: 652–657.
van Kraaij MG, van Elden LJ, van Loon AM, Hendriksen KA, Laterveer L, Dekker AW et al. Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture. Clin Infect Dis 2005; 40: 662–669.
Wingard JR, Sostrin MB, Vriesendorp HM, Mellits ED, Santos GW, Fuller DJ et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1988; 46: 61–65.
Pecego R, Hill R, Appelbaum FR, Amos D, Bruckner CD, Feder A et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1986; 42: 515–517.
Breuer R, Or R, Lijovetzky G, Naparstek E, Engelhard D, Lafair J et al. Interstitial pneumonitis in T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1988; 3: 625–630.
Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED . Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107: 648–656.
Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J . Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 169–173.
Urbanski SJ, Kossakowska AE, Curtis J, Chan CK, Hutcheon MA, Hyland RH et al. Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Am J Surg Pathol 1987; 11: 965–971.
Wyatt SE, Nunn P, Hows JM, Yin J, Hayes MC, Catovsky D et al. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax 1984; 39: 887–894.
Beschorner WE, Saral R, Hutchins GM, Tutschka PJ, Santos GW . Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med 1978; 299: 1030–1036.
Sloane JP, Depledge MH, Powles RL, Morgenstern GR, Trickey BS, Dady PJ . Histopathology of the lung after bone marrow transplantation. J Clin Pathol 1983; 36: 546–554.
Cooke KR, Krenger W, Hill G, Martin TR, Kobzik L, Brewer J et al. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 1998; 92: 2571–2580.
Hildebrandt GC, Olkiewicz KM, Choi S, Corrion LA, Clouthier SG, Liu C et al. Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation. Blood 2005; 105: 2249–2257.
Yoshihara S, Tateishi U, Ando T, Kunitoh H, Suyama H, Onishi Y et al. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005; 35: 1195–1200.
Chien JW, Madtes DK, Clark JG . Pulmonary function testing prior to hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 429–435.
Acknowledgements
We thank Dr P Westers, statistician at the Department of Biostatistics, for his help in the statistical analysis of this study. We are also grateful to Dr E Meijer (Department of Hematology, University Medical Center Utrecht) and Dr MGJ van Kraaij (Department of Hematology, University Medical Center Nijmegen) for providing their data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huisman, C., van der Straaten, H., Canninga-van Dijk, M. et al. Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant 38, 561–566 (2006). https://doi.org/10.1038/sj.bmt.1705484
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bmt.1705484
Keywords
This article is cited by
-
Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation
International Journal of Hematology (2023)
-
Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
International Journal of Hematology (2022)
-
Patterns of onset and outcome of cryptogenic organizing pneumonia after allogeneic hematopoietic stem cell transplantation
International Journal of Hematology (2019)
-
Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation
Frontiers of Medicine (2019)
-
Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation
Bone Marrow Transplantation (2013)


